| From : | |
| To : | Kim Matthis <Kim.MATTHIS@EUMM.EU> |
| Subject : | RE: Test |
| Received On : | 09.06.2020 14:38 |
Dear Kim
COVID19-Ag rapid tests and IgG/lgM are serological tests and are using serosurveillance studies. If it is possible we can buy both tests and reduce number of tests.
With bets regards, Keti
From: Kim Matthis [mailto:Kim.MATTHIS@EUMM.EU]
Sent: 9 June, 2020 13:33
To: Ketevan Goginashvili
Subject: RE: Test
Dear Keti,
Many thanks for your email and your valuable input. Would you be ok then that we update the budget with COVID19-Ag rapid tests instead as WHO recommendation is that IgG/lgM is to be only used serosurveillance studies? Please let me know what you think.
All the best,
Kim
From: Ketevan Goginashvili <kgoginashvili@moh.gov.ge>
Sent: 09 June 2020 13:19
To: Kim Matthis <Kim.MATTHIS@EUMM.EU>
Subject: RE: Test
CAUTION: This email originated from outside of the organization. Please do not click links or open attachments unless you recognize the source of this email and know the content is safe. |
Dear Kim,
Thank you for your attention and support.
According to the laboratory testing algorithm (Ministerial decree N01-144/o 01.04.2020), laboratories use COVID19-Ag rapid tests (cost per unit $15 by WHO) and COVID19- IgG/lgM Tests to diagnose covid-19.
With best regards, Keti
From: Kim Matthis [mailto:Kim.MATTHIS@EUMM.EU]
Sent: 9 June, 2020 11:16
To: Ketevan Goginashvili <kgoginashvili@moh.gov.ge>
Subject: Test
Dear Keti,
Just following up on our conversation this morning as we understand that the IgG/lgM test are only recommended for serosurveillance studies. If you could provide me with another test type or two as well as cost/test, that would be great. This is the last piece of information I would need from my side before I will send you the budget again for review and ask you to fill in a few last documents needed for contracting.
All the best,
Kim
This email was scanned by Bitdefender